Gushengtang Holdings Ltd
HKEX:2273
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Gushengtang Holdings Ltd
Net Issuance of Debt
Gushengtang Holdings Ltd
Net Issuance of Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
Gushengtang Holdings Ltd
HKEX:2273
|
Net Issuance of Debt
-¥14.3m
|
CAGR 3-Years
45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
|
Net Issuance of Debt
¥120.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Topchoice Medical Co Inc
SSE:600763
|
Net Issuance of Debt
¥111m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
|
Net Issuance of Debt
-¥41.3m
|
CAGR 3-Years
43%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
6%
|
|
|
Dian Diagnostics Group Co Ltd
SZSE:300244
|
Net Issuance of Debt
-¥944.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
|
Net Issuance of Debt
¥395.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
3%
|
|
Gushengtang Holdings Ltd
Glance View
Gushengtang Holdings Ltd. has woven itself into the fabric of China's healthcare system by focusing on traditional Chinese medicine (TCM), an industry deeply embedded in the nation's culture and ethos. The company operates a network of clinics that provide an array of services, from herbal medicine consultations to acupuncture treatments, leveraging China's growing demand for holistic healthcare solutions. By embracing both traditional practices and modern healthcare technologies, Gushengtang has positioned itself as a key player in delivering health services that resonate with a significant portion of the Chinese population who seek alternatives to Western medicine. Revenue streams for Gushengtang are multifaceted. The company earns primarily through the fees charged for consultations and treatments offered at its clinics, while also generating income from the sale of TCM products. Furthermore, by cultivating partnerships with health institutions and expanding its franchise network, Gushengtang enhances its reach and scalability. The integration of technology has allowed the firm to streamline operations and offer additional services like telemedicine, adapting to the digital shift in healthcare and tapping into the broader wellness market. This diversified approach not only fortifies its market position but ensures a steady flow of revenue in a competitive industry.
See Also
What is Gushengtang Holdings Ltd's Net Issuance of Debt?
Net Issuance of Debt
-14.3m
CNY
Based on the financial report for Dec 31, 2025, Gushengtang Holdings Ltd's Net Issuance of Debt amounts to -14.3m CNY.
What is Gushengtang Holdings Ltd's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 3Y
45%
Over the last year, the Net Issuance of Debt growth was 0%. The average annual Net Issuance of Debt growth rates for Gushengtang Holdings Ltd have been 45% over the past three years .